Bowel cancer is the fourth most common cancer in the UK, and the second most common cause of cancer death. The disease falls ...

Researchers have shown that the amount of a protein called CD74 can indicate which people with bowel cancer may respond best to immunotherapy.

Researchers at the Francis Crick Institute and Barts Cancer Institute, Queen Mary University of London, have shown that the amount of a protein called CD74 can indicate which people with bowel cancer ...

In addition, IgA antibodies against CD74, involved in the assembly of and the prevention of premature peptide-binding to major histocompatibility complex (MHC) class II has been shown in patients with ...